Denali Therapeutics Inc.
Kinase Inhibitors and Uses Thereof

Last updated:

Abstract:

The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Status:
Application
Type:

Utility

Filling date:

26 Oct 2021

Issue date:

10 Feb 2022